west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "贲门癌" 33 results
  • 空肠间置术预防贲门癌术后反流性食管炎

    目的探讨贲门癌近端胃切除空肠间置术后预防反流性食管炎的效果. 方法贲门癌近端胃切除空肠间置术患者,于术后作胃镜和消化道 X线钡餐造影,48例患者于术后7天和2~3个月行连续24小时pH值监测,以评价食管反流的情况. 结果 6例术后出现反流性食管炎,发生率9.68%. 结论采用空肠间置术行消化道重建对预防贲门癌术后反流性食管炎具有良好的临床效果.

    Release date:2016-08-30 06:32 Export PDF Favorites Scan
  • 贲门癌术后吻合口复发癌的再手术治疗

    目的 探讨贲门癌术后吻合口复发癌再手术的可能性和适应证. 方法 再次手术采用胸腹联合切口和左胸切口,手术切除9例,术中姑息性置管2例,探查3例. 结果 术后发生严重并发症2例,无手术及院内死亡.手术切除者中2年和3年生存率分别为44.4%(4/9)和22.2%(2/9),5例分别在7个月~2年内死亡,2例失访.置管及探查者均在2~7个月内死亡. 结论 贲门癌术后吻合口复发癌再手术要求较高,须严格掌握手术适应证.如患者一般情况较好,病灶较小,无远处转移,仍可再次积极手术,尤其是首次经腹手术者为佳.

    Release date:2016-08-30 06:35 Export PDF Favorites Scan
  • 多药耐药基因和多药耐药相关蛋白基因在食管、贲门癌中的表达

    目的 探讨多药耐药基因(MDR1)和多药耐药相关蛋白基因(MRP)在食管癌、贲门癌中表达的临床意义.方法 采用逆转录-多聚酶链反应(RT-PCR),对29例食管癌、贲门癌癌组织及癌旁组织中MDR1和MRP的表达进行检测.结果 癌组织中MDR1阳性率为65.5%,高于癌旁组织中MDR1的阳性率,为37.9%(P<0.05),癌组织MDR1信使核糖核酸(mRNA)表达水平也显著高于癌旁组织(P<0.01);癌组织的MRP阳性率为48.3%,高于癌旁组织(27.6%),但无差异(P>0.05),而癌组织MRP mRNA表达水平与癌旁组织比较则有差异(P<0.05);中、低分化肿瘤的MDR1和MRP表达阳性率增高,两基因的mRNA表达水平显著高于高分化肿瘤(P<0.05).结论 食管、贲门癌具有内源性多药耐药性;MDR1和MRP表达与食管、贲门癌的组织学类型及TNM分期无关,但可反映其肿瘤组织分化不良的生物学特征.

    Release date:2016-08-30 06:35 Export PDF Favorites Scan
  • Antireflux Effects of Different Reinforcement Procedure in Mechanical Anastomosis for Esophageal and Cardiac Carcinoma

    ObjectiveTo compare the antireflux effects of lip reinforcement, His angle reconstruction with fundoplication, and mechanical anastomosis only in mechanical anastomosis for esophageal and cardiac carcinoma. MethodsOne hundred and seventysix patients with esophageal or cardiac carcinoma admitted to this hospital between March 2008 and October 2009 were included, which were divided into mechanical anastomosis group (n=42), His angle reconstruction group(n=56), and lip reinforcement group (n=78) according to the sequence of admission. Mechanical anastomosis only, mechanical anastomosis His angle reconstruction with fundoplication, and mechanical anastomosis liptype reinforcement were performed in the corresponding group, respectively. Endoscopy and biopsy were conducted to evaluate the antireflux effects on 3 months after operation. ResultsThere were no differences on the gender, age, tumor location, anastomosis site, and incision among three groups (Pgt;0.05). The reflux rates of the mechanical anastomosis group, His angle reconstruction group, and lip reinforcement group were 69.05%, 28.57%, and 14.10%, respectively. The reflux rates in the lip reinforcement group and His angle reconstruction group were significantly lower than those in the mechanical anastomosis group (χ2=37.088, P=0.000; χ2=15.833, P=0.000), moreover, the rate in the lip reinforcement group was significantly lower than that in the His angle reconstruction group (χ2=4.241, P=0.039). There was no anastomotic leakage in the lip reinforcement group and all patients safely discharged from hospital after surgery, only 2 patients had moderately anastomotic stenosis and both of them had good recovery with endoscopic dilatationl. The reflux after operation was independent of anastomosis sites (Pgt;0.05). ConclusionBoth liptype reinforcement and His angle reconstruction can improve the ability of antireflux, liptype reinforcement is better and simple to mainpulate.

    Release date:2016-09-08 04:25 Export PDF Favorites Scan
  • Clinical Application of Trans abdominal Operation in Cardiac Cancer

    目的:探讨不同手术入路在贲门癌治疗中的临床应用。方法:回顾性分析我院2003年8月至2009年1月期间收治的153例贲门癌患者的临床资料,根据不同手术入路分为经腹组(n=74)、胸腹联合组(n=27)和经胸组(n=52),对3组患者的手术中、术后恢复情况以及随访结果进行对比分析。结果:手术切除率100%,围手术期无死亡病例。经腹组手术时间短于经胸组和胸腹联合组,术中出血量也少于经胸组和胸腹联合组,但差异无统计学意义(Pgt;0.05)。胸腹联合组和经腹组清扫的淋巴结数目明显多于经胸组,差异有统计学意义(Plt;0.05)。经腹组患者术后住院时间和术后并发症发生率明显少于胸腹联合组和经胸组,差异有统计学意义(Plt;0.05)。3组患者的术后局部复发率和远处转移率的差异均无统计学意义(Pgt;0.05),3年和5年生存率的差异也无统计学意义(Pgt;0.05)。结论:经腹贲门癌切除术是安全和有效的,配合吻合器的使用,操作也是可行的。

    Release date:2016-09-08 10:04 Export PDF Favorites Scan
  • 术前介入化疗对贲门癌患者免疫功能的影响

    Release date:2016-08-29 09:18 Export PDF Favorites Scan
  • The Clinical Application Research of Gastric Tube in Surgeries to Treat Esophageal and Cardial Carcinoma

    Abstract: Objective To Evaluate the clinical outcome of gastric tube in radical surgeries to treat esophageal and cardial carcinoma. Methods From January to October 2008, 74 patients with esophageal or cardial carcinoma in Ruijin Hospital were enrolled in our study. Based on the surgical method, they were divided into the gastric tube group and the traditional way group. The gastric tube group had 46 patients, including 36 male patients and 10 female patients, whose age averaged 59.67±9.96 years (36 to 77 years). Among them, 31 patients had esophageal carcinoma with 1 upper, 23 middle and 7 lower esophageal carcinoma, and 15 patients had cardial carcinoma. In this group, 2 patients were treated with anastomosis in the left neck, 19 with anastomosis in the upper aortic arch, 10 with anastomosis in the lower aortic arch and 15 cardial carcinoma patients underwent radical resection. In the traditional way group, there were 28 patients, 25 male patients and 3 female patients, whose age averaged 59.17±11.33 years (37 to 86 years). In these patients, 22 had esophageal carcinoma with 1 in the upper esophagus, 17 in the middle esophagus, 4 in the lower esophagus; and 6 patients had cardial carcinoma. In this group, 2 patients were treated with anastomosis in the left neck , 17 with anastomosis in the upper aortic arch, 3 with anastomosis in the lower aortic arch, and 6 cardial carcinoma patients underwent radical resection. The rate of anastomotic leakage, operation time, and length of stay in hospital of these two groups were observed. Results All surgeries in the two groups were successfully performed. There was no anastomotic leakage case in the gastric tube group, while there were 4 pulmonary infection cases and 1 death case in the traditional way group. There was no statistically difference in the operation time (180.00±10.34 min vs. 185.00±6.23 min, t=1.669, P=0.078) and length of stay in hospital (16.78±9.98 d vs. 16.89±11.53 d, t=1.665, P=0.075) between the gastric tube group and the traditional way group. Conclusion Gastric tube has a good value in clinical application with fewercomplications and without prolonging operation and hospitalization time, which can surely better quality of life of the patients.

    Release date:2016-08-30 06:01 Export PDF Favorites Scan
  • 食管癌或贲门癌术后乳糜腹的压力治疗

    目的证明腹腔束带加压对于食管癌或贲门癌术后乳糜腹的有效性,并探讨其使用的条件和优缺点。 方法总结四川大学华西医院胸外科2009~2013年行食管癌或贲门癌切除术的3 859例患者中术后出现乳糜腹的4例患者接受加压治疗的情况,对其治疗经过和结局进行分析,其中男3例、女1例,年龄59~68岁。 结果4例患者中,3例加压成功患者均在两周内治愈,随访超过1年时间未见乳糜腹复发,1例患者因腹部加压后乳糜液持续漏入胸腔,导致无法成功加压,治疗失败,最终通过再次手术治愈。 结论在保证腹腔是一个封闭空间及足够压力和时间的前提下,加压治疗对腹部术后乳糜腹有效,且无创、时间短、风险低及不需禁食,其缺点是患者治疗前期有腹腔加压的不适感。

    Release date:2016-10-02 04:56 Export PDF Favorites Scan
  • 食管、贲门癌术后胸胃排空障碍14例

    目的 探讨食管、贲门癌术后胸胃排空障碍的治疗措施,以提高术后胸胃排空障碍的疗效。 方法 14例食管、贲门癌术后发生胸胃排空障碍患者中有3例给予保守治疗,11例经保守治疗效果不佳者在胃镜下安置鼻空肠营养管行肠内营养支持治疗,其中2例仍无效者行剖腹探查,幽门成形加空肠造瘘术。 结果 所有患者全部康复,其中3例经保守治疗1周治愈;11例在胃镜下安置鼻空肠营养管给予肠内营养治疗者中有9例于2周内拔除胃管,恢复正常饮食,2例行幽门成形加空肠造瘘术,术后2周治愈出院。所有患者随访3~6个月,进普通食物无恶心、呕吐。消化道X线钡餐检查显示:吞服钡剂后胸胃无钡剂潴留和明显扩张。 结论 在胃镜下安置鼻空肠营养管给予肠内营养是治疗胸胃排空障碍的一种有效方法,且安全可靠、方便经济;对疗效欠佳的患者,宜尽早行剖腹探查加幽门成形术。

    Release date:2016-08-30 06:05 Export PDF Favorites Scan
  • Effect Comparison of the Negative Pressure Ball with Small Tube for Thoracic Drainage after Esophageal and Cardiac Cancer Surgery

    【摘要】目的观察负压球在食管癌、贲门癌术后的临床应用价值。方法1999年2009年对观察组食管癌、贲门癌术后使用负压球细管引流,对照组术后使用传统粗胶管水封瓶闭式引流,两组均286例。结果观察组在胸腔积液、第二天镇痛剂应用、引流口感染及术后住院时间等方面与对照组相比差异有统计学意义,而术后脓胸、第一天镇痛剂应用及管腔堵塞等方面与对照组相比无差异。结论负压球细管引流用于食管癌、贲门癌术后胸腔引流,创伤小,效果确切满意。

    Release date:2016-09-08 09:31 Export PDF Favorites Scan
4 pages Previous 1 2 3 4 Next

Format

Content